TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Federica Orvieto
Senior Research Investigator, Peptide Chemistry at IRBM Science Park SPA

Profile

After her degree in Pharmaceutical Chemistry at the University of Siena, Federica joined IRBM-Merck Research Laboratories Rome as a medicinal chemist. She has contributed to the development of preclinical candidates in different therapeutic area and she was part of the team discovering the first in class HIV Integrase Inhibitor ISENTRESS ®. In 2010 she joined IRBM Science Park as group leader in the Peptide Chemistry group working on different peptide drug discovery programs. Federica has a broad pharmaceutical experience both in the development of peptide therapeutics, macrocycles and small molecules. She is author of several scientific publications in peer-reviewed journals and co-inventor in several patents.

Federica Orvieto's Network

Agenda Sessions

  • Early Implementation of Appropriate Studies to Identify Preclinical Liabilities is Key to Success in Peptide Drug Discovery

    , 14:00